Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Hisada

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|March 17, 2022
Intertwined pathways of complement activation command the pathogenesis of lupus nephritisAbhigyan Satyam, Ryo Hisada, Rhea Bhargava, et al.
International Journal of Rheumatic Diseases|November 20, 2025
Predictive Factors for Renal Outcome During Remission Induction Treatment Period in Lupus NephritisKazuro Kamada, Michihito Kono, Shuhei Takeyama, et al.
Internal Medicine (Tokyo, Japan)|February 17, 2017
Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and CyclophosphamideEri Sugawara, Masaru Kato, Ryo Hisada, et al.
Modern Rheumatology|August 26, 2024
Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort studyJiang Wei, Yuichiro Fujieda, Yusuke Fujita, et al.
Modern Rheumatology|February 22, 2019
Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot studyAtsushi Noguchi, Shinsuke Yasuda, Ryo Hisada, et al.
Immunological Medicine|October 11, 2025
Factors related to seroconversion of anti-cyclic citrullinated peptide antibody after the onset of rheumatoid arthritis: a case-control study and systematic reviewYui Kosumi, Ryoko Asano, Aki Sugano, et al.
Lupus|June 23, 2026
Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndromeYuta Inoue, Hiroyuki Nakamura, Yuichiro Fujieda, et al.
Rheumatology (Oxford, England)|December 6, 2025
The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with antiphospholipid syndromeHaruka Moriya, Ryo Hisada, Yuichiro Fujieda, et al.
Rheumatology (Oxford, England)|December 4, 2018
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndromeNaoki Ohnishi, Yuichiro Fujieda, Ryo Hisada, et al.
Rheumatology (Oxford, England)|April 17, 2016
Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndromeKenji Oku, Olga Amengual, Ryo Hisada, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Translational Research : the Journal of Laboratory and Clinical Medicine|March 17, 2022
Intertwined pathways of complement activation command the pathogenesis of lupus nephritisAbhigyan Satyam, Ryo Hisada, Rhea Bhargava, et al.
International Journal of Rheumatic Diseases|November 20, 2025
Predictive Factors for Renal Outcome During Remission Induction Treatment Period in Lupus NephritisKazuro Kamada, Michihito Kono, Shuhei Takeyama, et al.
Internal Medicine (Tokyo, Japan)|February 17, 2017
Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and CyclophosphamideEri Sugawara, Masaru Kato, Ryo Hisada, et al.
Modern Rheumatology|August 26, 2024
Phosphatidylserine-dependent antiprothrombin antibodies as a key predictor for systemic lupus erythematosus in patients with primary antiphospholipid syndrome: A retrospective longitudinal cohort studyJiang Wei, Yuichiro Fujieda, Yusuke Fujita, et al.
Modern Rheumatology|February 22, 2019
Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot studyAtsushi Noguchi, Shinsuke Yasuda, Ryo Hisada, et al.
Immunological Medicine|October 11, 2025
Factors related to seroconversion of anti-cyclic citrullinated peptide antibody after the onset of rheumatoid arthritis: a case-control study and systematic reviewYui Kosumi, Ryoko Asano, Aki Sugano, et al.
Lupus|June 23, 2026
Longitudinal observation of thrombotic events in patients with obstetric antiphospholipid syndromeYuta Inoue, Hiroyuki Nakamura, Yuichiro Fujieda, et al.
Rheumatology (Oxford, England)|December 6, 2025
The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with antiphospholipid syndromeHaruka Moriya, Ryo Hisada, Yuichiro Fujieda, et al.
Rheumatology (Oxford, England)|December 4, 2018
Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndromeNaoki Ohnishi, Yuichiro Fujieda, Ryo Hisada, et al.
Rheumatology (Oxford, England)|April 17, 2016
Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndromeKenji Oku, Olga Amengual, Ryo Hisada, et al.
Pageof 5